---
layout: default
---


### Single Study Visualizations

<div class="pure-g">
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide2.PNG" 
       data-lightbox="slide-2"
       data-lightbox-caption="Summary View for Numeric Data"> 
      <img class="thumbsize" src="/assets/se-images/Slide2.PNG" alt="" />
    </a>
    <p class="thumbtitle">Summary View for Numeric Data</p>
    <p class="thumbsize">…to visualize patterns and trends in numeric data with summary statistics, scatterplot, out of concurrent control range indicator, and % control mean calculations</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide3.PNG" 
       data-lightbox="slide-3"> 
      <img class="thumbsize" src="/assets/se-images/Slide3.PNG" alt="" />
    </a>
    <p class="thumbtitle">Summary View Detail</p>
    <p class="thumbsize">…to review thumbnail visualizations or display detailed view showing distribution of subject data across groups</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide1.PNG" 
       data-lightbox="slide-1"> 
      <img class="thumbsize" src="/assets/se-images/Slide1.PNG" alt="" />
    </a>
    <p class="thumbtitle">Severity Heatmap</p>
    <p class="thumbsize">…to visualize patterns and trends in both incidence and severity</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide4.PNG" 
       data-lightbox="slide-4"> 
      <img class="thumbsize" src="/assets/se-images/Slide4.PNG" alt="" />
    </a>
    <p class="thumbtitle">Cross-Domain Subject View</p>
    <p class="thumbsize">…to put a subject’s data into perspective as compared to its own group and control group, on a single day or over time</p>
  </div>
</div>

### Multi-Study Visualizations

<div class="pure-g">
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide5.PNG" 
       data-lightbox="slide-5"> 
      <img class="thumbsize" src="/assets/se-images/Slide5.PNG" alt="" />
    </a>
    <p class="thumbtitle">Correlations Matrix</p>
    <p class="thumbsize">…to reveal pairwise correlations of endpoints for selected subjects, identifying those with histopathology findings in tissues of interest.</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide6.PNG" 
       data-lightbox="slide-6"> 
      <img class="thumbsize" src="/assets/se-images/Slide6.PNG" alt="" />
    </a>
    <p class="thumbtitle">Multi-Study Timecourse Grid</p>
    <p class="thumbsize">…to compare the timecourse pattern of selected endpoint(s) across studies of interest.</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide7.PNG" 
       data-lightbox="slide-7"> 
      <img class="thumbsize" src="/assets/se-images/Slide7.PNG" alt="" />
    </a>
    <p class="thumbtitle">Histopathology Treemap</p>
    <p class="thumbsize">…to visualize relative prevalence of histopathology findings across studies.</p>
  </div>
  <div class="pure-u-1-2">
    <a href="/assets/se-images/Slide8.PNG" 
       data-lightbox="slide-8"> 
      <img class="thumbsize" src="/assets/se-images/Slide8.PNG" alt="" />
    </a>
    <p class="thumbtitle">Historical Control Distribution</p>
    <p class="thumbsize">…to reveal the distribution of selected control data across studies, stratified by fields of interest.</p>
  </div>
</div>


### The INDS Advantage

The specialized, complementary expertise of our team members enables INDS to
provide you drug development support from target selection to product
registration. Our data management and information technology specialists work
closely with our toxicologists to deliver software solutions that truly reflect
end-user needs for ease-of-use and flexibility. Our team consists of board
certified toxicologists, veterinarians, and information technology and business
operations experts with more than 100 years of combined experience in the
pharmaceutical and contract research industries.

### Our Experience

-   Advancing over 120 compounds in all major therapeutic areas to clinical
    trials, using both traditional and alternative paradigms, including filing
    industry's first exploratory IND.
-   Advancing compounds to market, including several first-in-class drugs
    (Cognex®, ReZulin®, Neurontin®, LYRICA®) and the world's best selling drug
    Lipitor®, through design and execution of standard studies and extensive
    mechanistic investigations.
-   Developing innovative informatics solutions including state-of-the-art data
    warehousing, data visualization, interpretations and automated
    reporting tools.
-   Integrating and implementing SEND 3.0.

### Committed To Your Success

Whether you lack internal safety expertise or need to supplement your internal
resources to meet peak demands, contact INDS. We have the know-how you need to
succeed.
